CDKN1B and prostate carcinoma: The presence of a hemizygous deletion of the CDKN1B gene in human hematopoietic malignancies, ovarian and prostate cancers, associated with a reduced expression of P27 is indicative of a CDKN1B haploinsufficient behavior in those tumors (25).